Yield10 Bioscience Announces Second Quarter 2024 Financial Results
WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024.
Related news for (YTEN)
- Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets
- Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina
- Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label
- Yield10 Bioscience Announces First Quarter 2024 Financial Results